FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34794111000001100: Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105536001000001118 Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105536101000001117 Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Is a Ponatinib 30mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has AMP Iclusig 30mg tablets (Incyte Biosciences UK Ltd) true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has specific active ingredient Ponatinib hydrochloride true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ponatinib true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start